ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 100 filers reported holding ADMA BIOLOGICS INC in Q3 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $523,854 | +236.0% | 146,328 | +246.3% | 0.00% | – |
| Q2 2023 | $155,902 | +37.0% | 42,250 | +44.0% | 0.00% | – |
| Q4 2022 | $113,816 | -65.4% | 29,334 | -83.7% | 0.00% | -100.0% |
| Q1 2022 | $329,000 | +600.0% | 179,996 | +435.1% | 0.00% | – |
| Q4 2021 | $47,000 | -54.8% | 33,635 | -63.4% | 0.00% | – |
| Q3 2021 | $104,000 | -77.9% | 91,926 | -68.7% | 0.00% | -100.0% |
| Q2 2021 | $470,000 | -53.6% | 293,859 | -48.9% | 0.00% | -66.7% |
| Q1 2021 | $1,013,000 | +325.6% | 575,325 | +370.4% | 0.01% | +200.0% |
| Q4 2020 | $238,000 | +466.7% | 122,301 | +590.7% | 0.00% | +100.0% |
| Q3 2020 | $42,000 | -82.0% | 17,706 | -77.7% | 0.00% | -75.0% |
| Q2 2020 | $233,000 | +323.6% | 79,444 | +318.5% | 0.00% | +300.0% |
| Q1 2020 | $55,000 | -57.7% | 18,982 | -41.7% | 0.00% | 0.0% |
| Q4 2019 | $130,000 | +80.6% | 32,559 | +180.7% | 0.00% | 0.0% |
| Q3 2018 | $72,000 | +44.0% | 11,600 | +5.0% | 0.00% | 0.0% |
| Q2 2018 | $50,000 | – | 11,046 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 9,104,275 | $32,593,305 | 10.83% |
| Altium Capital Management LP | 2,723,011 | $9,748,379 | 5.08% |
| Velan Capital Investment Management LP | 1,736,100 | $6,215,238 | 5.01% |
| AWM Investment Company, Inc. | 5,999,872 | $21,479,542 | 3.17% |
| Mesirow Financial Investment Management, Inc. | 72,677 | $260,184 | 1.13% |
| Caligan Partners LP | 597,513 | $2,139,097 | 0.98% |
| Perceptive Advisors | 6,984,319 | $25,003,862 | 0.83% |
| OBERWEIS ASSET MANAGEMENT INC/ | 2,078,400 | $7,440,672 | 0.79% |
| TANG CAPITAL MANAGEMENT LLC | 1,360,000 | $4,868,800 | 0.69% |
| EAM Investors, LLC | 967,146 | $3,462,383 | 0.67% |